INTERNATIONAL PATENT: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED FILES APPLICATION FOR "VIRAL-BASED IMMUNO THERAPEUTIC GENETIC CONSTRUCT COMPRISING UL40 INTO WHICH A TUMOUR-ASSOCIATED ANTIGENIC PEPTIDE IS INCORPORATED"

GENEVA, June 2 -- UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (c/o Dr Rhodri TurnerMain BuildingCardiff, South Glamorgan CF10 3AT) filed a patent application (PCT/GB2024/052929) for "VIRAL-BASED IMMUNO THERAPEUTIC GENETIC CONSTRUCT COMPRISING UL40 INTO WHICH A TUMOUR-ASSOCIATED ANTIGENIC PEPTIDE IS INCORPORATED" on Nov 20, 2024. With publication no. WO/2025/109316, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HUMPHREYS, Ian (University College Cardiff Consultants Limitedc/o Dr Rhodri TurnerMain BuildingCardiff, Sout...